Ophthalmologists must embrace corneal diagnostics to select the proper patient for premium multifocal IOLs, according to a ...
TECLens, Inc., a clinical-stage ophthalmic medical device company, announced today it raised $9.3 million in a Series A round co-led by Johnson & Johnson Innovation – JJDC Inc. and Yonjin Capital.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback